
FDA’s largest infant formula test yet finds ‘low’ contaminants – but no new rules
FDA’s infant formula test found mostly trace contaminants, but without standards, enforcement or pre‑market testing, the data leaves critical questions unanswered
All stories

FDA’s infant formula test found mostly trace contaminants, but without standards, enforcement or pre‑market testing, the data leaves critical questions unanswered

As GLP‑1 drugs reshape how people eat, food‑based bioactive peptides are emerging as a potential way to support satiety before, during and after drug use

Future Food-Tech San Francisco
An evolving class of GLP-1 medications rewrites the rules of appetite – giving food companies their biggest innovation challenge in decades

Little Spoon’s stricter sourcing and voluntary testing standards highlight the widening gap between emerging safety expectations and the infant formula industry’s recent failures

How advances in fiber chemistry and sourcing may influence the next generation of food products and health

FDA eases ‘no artificial colors’ claims, but ambiguity over ‘petroleum-based dyes’ leaves manufacturers cautious

FDA acknowledges brazzein-54, advancing Oobli’s nature-identical sweet protein toolkit to reduce sugar

The brand is betting on a “gut health glow-up,” refreshing its brand and product lineup to win over the next generation of wellness-minded consumers

Sustainable September
German company looks to US collaborators to scale compostable bottles

Ingredient innovation and demand for preventive health drive growth in the nutrition and snack bar category